Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients

Journal of Clinical Psychopharmacology

Volumn 21, Issue 3, 2001, Pages 268-272

  Tweedy, Christine M ^a   Milgrom, Peter ^a   Kharasch, Evan D ^a   Kaakko, Tarja ^a   Spieker, Martha ^a   Coldwell, Susan E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAZOLAM;

AMNESIA; AREA UNDER THE CURVE; ARTICLE; ATAXIA; CHILD; CLINICAL TRIAL; DENTAL ANESTHESIA; DIPLOPIA; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADMINISTRATION, SUBLINGUAL; AMNESIA; ANTI-ANXIETY AGENTS; AREA UNDER CURVE; ATAXIA; CHILD; CHILD, PRESCHOOL; DENTAL CARE FOR CHILDREN; DIPLOPIA; FEMALE; HUMANS; LINEAR MODELS; MALE; TRIAZOLAM;

EID: 0035008876     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200106000-00004     Document Type: Article

References (27)

1. Wright GZ, Starkey PE, Gardner DE. Child management in dentistry. Oxford: Butterworth-Heinemann Ltd., 1987.
2. Fuks AB, Kaufman E, Ram D, et al. Assessment of two doses of intranasal midazolam for sedation of young pediatric dental patients. Pediatr Dent 1994;16:301-5.
3. Hartgraves PM, Primosch RE. An evaluation of oral and nasal midazolam for pediatric dental sedation. ASDC J Dent Child 1994; 61:175-81.
4. Meyer ML, Mourino AP, Farrington FH. Comparison of triazolam to a chloral hydrate/hydroxyzine combination in the sedation of pediatric dental patients. Pediatr Dent 1990;12:283-7.
5. Quamstrom FC, Milgrom P, Moore PA. Experience with triazolam in preschool children. Anesth Pain Control Dent 1992;1:157-9.
6. Haas DA, Nenniger SA, Yacobi R, et al. A pilot study of the efficacy of oral midazolam for sedation in pediatric dental patients. Anesth Prog 1996;43:1-8.
7. Rothschild AJ. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. J Clin Psychiatry 1992;53[suppl 12]:69-79.
8. Karl HW, Milgrom P, Domoto P, et al. Pharmacokinetics of oral triazolam in children. J Clin Psychopharmacol 1997;17:169-72.
9. Coldwell SE, Awamura K, Milgrom P, et al. Side effects of triazolam in children. Pediatr Dent 1999;21:18-25.
10. Raadal M, Coldwell SE, Kaakko T, et al. A randomized clinical trial of triazolam in 3-to 5-year-olds. J Dent Res 1999;78:1197-203.
11. Pelco LE, Kissel RC, Parrish JM, et al. Behavioral management of oral medication administration difficulties among children: a review of literature with case illustration. J Dev Behav Pediatr 1987;8:90-6.
12. Griffith N, Howell S, Mason DG. Intranasal midazolam for premedication of children undergoing day-case anaesthesia: comparison of two delivery systems with assessment of intra-observer variability. Br J Anaesth 1998;81:865-9.
13. Kronbach T, Mathys D, Umeno M, et al. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 1989;36:89-96.
14. Villikka K, Kivistö KT, Backman JT, et al. Triazolam is ineffective in patients taking rifampin. Clin Pharmacol Ther 1997;61:8-14.
15. Scavone JM, Greenblatt DJ, Friedman H, et al. Enhanced bioavailability of triazolam following sublingual versus oral administration. J Clin Pharmacol 1986;26:208-10.
16. Kroboth PD, McAuley JW, Kroboth FJ, et al. Triazolam pharmacokinetics after intravenous, oral, and sublingual administration. J Clin Psychopharmacol 1995;15:259-62.
17. Berthold CW, Dionne RA, Corey SE. Comparison of sublingually and orally administered triazolam for premedication before oral surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:119-24.
18. Russell WJ, Badcock NR, Frewin DB, et al. Pharmacokinetics of a new sublingual formulation of temazepam. Eur J Clin Pharmacol 1988;35:437-9.
19. Greenblatt DJ, Divoll M, Harmatz JS, et al. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. J Pharm Sci 1982;71:248-52.
20. Flaitz CM, Nowak AJ, Hicks MJ. Evaluation of the anterograde amnesic effect of rectally administered diazepam in the sedated pedodontic patient. ASDC J Dent Child 1986;53:17-20.
21. Worth C. Squint: its causes, pathology and treatment. 4th ed. Philadelphia: Blakiston's Sons & Co., 1915.
22. Simons K, Elhatton K. Artifacts in fusion and stereopsis testing based on red/green dichoptic image separation. J Pediatr Ophthalmol Strabismus 1994;31:290-7.
23. McDonald RE, Avery DR. Dentistry for the child and adolescent. St. Louis: Mosby-Year Book, 1994.
24. Greenblatt DJ, Wright CE, von Moltke LL, et al. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences. Clin Pharmacol Ther 1998;64: 237-47.
25. Mathews HM, Carson IW, Lyons SM, et al. A pharmacokinetic study of midazolam in paediatric patients undergoing cardiac surgery. Br J Anaesth 1988;61:302-7.
26. Greenblatt DJ, Abernethy DR, Locniskar A. et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984; 61:27-35.
27. Allonen H, Ziegler G, Klotz U. Midazolam kinetics. Clin Pharmacol Ther 1981;30:653-61.